Skip to main content
Ir a la página de inicio de la Comisión Europea (se abrirá en una nueva ventana)
español es
CORDIS - Resultados de investigaciones de la UE
CORDIS

Advancing Breast cancer Individualised Generative AI for Longitudinal Outcomes

Objetivo

ABIGAIL4D pioneers a new approach to personalised oncology by developing and validating a 4D Generative AI system prototype that can learn disease evolution over time and support safer, more informed treatment decisions in early breast cancer. Today, decision support tools rely on static or single-modality data and cannot estimate how an individual patient would respond to alternative therapies. This limits clinical ability to compare options and optimise outcomes.
ABIGAIL4D combines multimodal longitudinal data, including imaging, pathology, genomics, and clinical variables, into a temporal model that reconstructs and forecasts tumour response, survival and toxicity. The system introduces counterfactual analysis to estimate patient-specific benefit and risk for different treatment strategies, such as escalation and de-escalation of chemotherapy or radiotherapy. Specialised AI agents (Radiology, Pathology, Oncology and Patient) collaborate through a stateful orchestrator to generate explainable recommendations with quantified uncertainty. Clinicians remain in control at all times, supported by transparent rationales linked to clinical concepts and guidelines.
The methodology follows a staged design: requirements co-creation with clinicians; development of the GenAI backbone and multi-agent framework; trust-by-design mechanisms for traceability, reproducibility and explainability; and validation in controlled, multi-centre lab settings. Regulatory documentation aligned with EU Medical Device Regulation and the AI Act will support future certification.
ABIGAIL4D AI agents and system, aim at enabling in the future personalised treatment decisions and more efficient care pathways. Expected benefits will include better therapy selection, fewer unnecessary scans and reduced burden for patients and healthcare systems. ABIGAIL4D provides a foundation for future expansion to other solid tumours, contributing to Europe’s leadership in responsible AI driven precision medicine

Ámbito científico (EuroSciVoc)

Palabras clave

Programa(s)

Tema(s)

Régimen de financiación

HORIZON-EIC - HORIZON EIC Grants

Ver todos los proyectos financiados en el marco de este régimen de financiación

Convocatoria de propuestas

(se abrirá en una nueva ventana) HORIZON-EIC-2025-PATHFINDERCHALLENGES-01

Ver todos los proyectos financiados en el marco de esta convocatoria

Coordinador

FUNDACIO EURECAT
Aportación neta de la UEn
€ 898 875,00
Dirección
AVENIDA UNIVERSITAT AUTONOMA 23
08290 Cerdanyola Del Valles (Barcelona)
España
Región
Este Cataluña Barcelona
Tipo de actividad
Research Organisations
Enlaces
Coste total
Sin datos

Participantes (9)